Health Care · Services-Offices & Clinics of Doctors of Medicine · OTC · CIK 1680139 · FYE Dec 31 · Prices AT CLOSE 2026-07-28 (USD) — end-of-day, never a live or intraday quote
Last $3.07Day +11.64%Mkt cap $9M1Y −12.3%Off 52W high −52.8%Vol (1Y) 197.7%
Daily closing price, split-adjusted to the current basis; 3y shown of 2,205 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest0.0% of sh out |
| Days to cover1.0d |
| 13F net flow (QoQ)+0.00% |
| Top-10 13F concentration100.0% |
| Next report (est.)2026-08-15 |
Short interest is FINRA semi-monthly, settlement 2026-06-30. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$1.7M |
| Earnings (TTM)-$3.9M |
| Net margin−158.8% |
| Sales growth 3Y−29.4% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+119.3% |
| 1Y−12.3% |
| 3Y−57.4% |
| 5Y−95.0% |
| Since incept. (ann.)−22.4% |
Total return through 2026-07-28 · series begins 2017-08-03. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)197.7% |
| Ann. volatility (3Y)172.7% |
| Sharpe (1Y)0.85 |
| Sharpe (3Y)0.66 |
| Max drawdown (1Y)−69.8% |
| Max drawdown (3Y)−86.6% |
| Beta (3Y vs SPY)1.97 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| Ancora Advisors LLC | 74 | $240 | 0.00% | +0.0% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-15 | −$0.56 | — | $423,465 | −45.3% |
| 2025-12-31 | 2026-03-31 | — | — | $310,179 | −49.9% |
| 2025-09-30 | 2025-11-19 | −$0.30 | — | $388,545 | −34.2% |
| 2025-06-30 | 2025-08-14 | $0.00 | — | $592,360 | −25.5% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-15 is ESTIMATED from filing cadence (median gap 92d) — not company-confirmed.
Health Services 97% · Medical Distribution 2% · Digital Healthcare 1%
business segments · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
